Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Lymphoma

Free Subscription Articles published in J Immunol Retrieve available abstracts of 7 articles: HTML format

Single Articles

February 2023
1. ABBOUD G, Choi SC, Zhang X, Park YP, et al
   Glucose Requirement of Antigen-Specific Autoreactive B Cells and CD4+ T Cells.
   J Immunol. 2023;210:377-388.
   PubMed     Abstract available
   
   
   October 2022
2. DOGAN M, Karhan E, Kozhaya L, Placek L, et al
   Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy.
   J Immunol. 2022;209:1523-1531.
   PubMed     Abstract available
   
   
   June 2022
3. JIA X, Bene J, Balazs N, Szabo K, et al
   Age-Associated B Cell Features of the Murine High-Grade B Cell Lymphoma Bc.DLFL1 and Its Extranodal Expansion in Abdominal Adipose Tissues.
   J Immunol. 2022;208:2866-2876.
   PubMed     Abstract available
   
   
   January 2022
4. TARSALAINEN A, Maman Y, Meng FL, Kylaniemi MK, et al
   Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.
   J Immunol. 2022;208:143-154.
   PubMed     Abstract available
   
   
   August 2021
5. DUBOIS S, Waldmann TA, Muller JR
   Effective Cytotoxicity of Dendritic Cells against Established T Cell Lymphomas in Mice.
   J Immunol. 2021;207:1194-1199.
   PubMed     Abstract available
   
   
   April 2021
6. JIANG C, Zhao ML, Ramos L, Dobaczewska K, et al
   The Role of IgM Antibodies in T Cell Lymphoma Protection in a Novel Model Resembling Anaplastic Large Cell Lymphoma.
   J Immunol. 2021 Apr 21. pii: jimmunol.2001279. doi: 10.4049/jimmunol.2001279.
   PubMed     Abstract available
   
   
   March 2021
7. MILANOVIC M, Shao Z, Estes VM, Wang XS, et al
   FATC Domain Deletion Compromises ATM Protein Stability, Blocks Lymphocyte Development, and Promotes Lymphomagenesis.
   J Immunol. 2021;206:1228-1239.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: